Molecular Carcinogenesis
-
Publication Venue For
- Pharmacologic inhibition of ataxia telangiectasia and Rad3-related (ATR) in the treatment of head and neck squamous cell carcinoma.. 61:225-238. 2022
- Regulation of p53-targeting microRNAs by polycyclic aromatic hydrocarbons: Implications in the etiology of multiple myeloma.. 54:1060-1069. 2015
- A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.. 46:488-496. 2007
- Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies.. 42:65-92. 2005
- Caspase-8 levels affect necessity for mitochondrial amplification in death ligand-induced glioma cell apoptosis.. 39:173-182. 2004
- Overexpression of hMTH in peripheral lymphocytes and risk of prostate cancer: a case-control analysis.. 36:123-129. 2003
- Thymic model for examining BRCA2 expression and function.. 35:103-109. 2002
- Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells.. 29:92-102. 2000
- Chromium(VI) induces p53-dependent apoptosis in diploid human lung and mouse dermal fibroblasts.. 28:111-118. 2000
- Vitamin D receptor polymorphisms and prostate cancer.. 27:18-23. 2000
- Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q.. 23:243-247. 1998
- Arrest of replication by mammalian DNA polymerases alpha and beta caused by chromium-DNA lesions.. 23:201-206. 1998
- Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization.. 19:273-279. 1997
- Altered expression of transforming growth factor-alpha: an early event in renal cell carcinoma development.. 19:213-219. 1997
- Dideoxy fingerprinting assay for BRCA1 mutation analysis.. 19:176-179. 1997
- Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer.. 17:160-162. 1996
- Potentiation of diethylstilbestrol-induced alterations in the female mouse reproductive tract by transforming growth factor-alpha transgene expression.. 17:163-173. 1996
- Mutational analysis of the p21/WAF1/CIP1/SDI1 coding region in human tumor cell lines.. 16:221-228. 1996
- Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.. 15:85-95. 1996
- Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus.. 15:154-161. 1996
- Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat.. 14:28-36. 1995
- p53 status in spontaneous and dimethylnitrosamine-induced renal cell tumors from rats.. 12:236-240. 1995
- DNA polymerase arrest by adducted trivalent chromium.. 9:122-133. 1994
- Creation of an active estrogen-responsive element by a single base change in the flanking sequence of a cellular oncogene: a possible mechanism for hormonal carcinogenesis?. 7:76-82. 1993
- Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosomes 3 and 11 introduced via microcell-mediated chromosome transfer.. 7:157-164. 1993
- Evidence for coincident mutations in human lymphoblast clones selected for functional loss of a thymidine kinase gene.. 5:270-277. 1992
- Transcriptional inhibition by carcinogenic chromate: relationship to DNA damage.. 6:270-279. 1992